Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/10/2025

Treatment of Bartonella Retinitis

Primary Treatment Regimen

  • The CDC recommends a combination therapy of doxycycline plus rifampin for at least 3 months for Bartonella infections involving the eye and central nervous system, with doxycycline 100 mg twice daily PLUS rifampin 300-600 mg daily 1, 2
  • This combination addresses both the infection and prevents recurrence, which is common with Bartonella, as recommended by the CDC and supported by the MMWR Recommendations and Reports 1, 3

Alternative Regimens

  • For patients who cannot tolerate doxycycline, erythromycin (30-50 mg/kg body weight, maximum 2 g/day) is an acceptable first-line alternative, as recommended by the Praxis Medical Insights 1
  • Azithromycin 500 mg daily plus rifampin 300-600 mg daily can be used as an alternative regimen, as recommended by the Praxis Medical Insights 2

Treatment Duration and Monitoring

  • A minimum of 3 months of antibiotic therapy is recommended for ocular Bartonella infection, as recommended by the Praxis Medical Insights 1, 2
  • Longer courses (4-6 months) may be necessary for complicated or persistent disease, as recommended by the Praxis Medical Insights 2
  • Clinical assessment every 2-4 weeks to monitor visual improvement is recommended, as suggested by the Praxis Medical Insights 2

Ineffective Treatments to Avoid

  • Penicillins and first-generation cephalosporins have no in vivo activity against Bartonella and should never be used, as recommended by the Praxis Medical Insights 1, 2
  • TMP-SMX and quinolones as monotherapy have inconsistent clinical response and are not recommended, as recommended by the Praxis Medical Insights 1, 2

Prevention of Recurrence

  • For immunocompromised patients, consider long-term suppressive therapy with doxycycline or a macrolide after completing initial treatment, as recommended by the MMWR Recommendations and Reports and the Praxis Medical Insights 1, 3

Pediatric Considerations

  • For children with Bartonella neuroretinitis, doxycycline 2-4 mg/kg body weight (maximum 100-200 mg/day) divided into 1-2 doses is recommended, as suggested by the Praxis Medical Insights 1